Intriguingly, alterations in NAMPT levels are associated with metabolic disorders and cancer [238], while FK866 (a highly specific NAMPT inhibitor that abolishes NAD+ circadian oscillations and SIRT1 cycle activity) can induce apoptosis in human cancer cells [236, 239]. The gene discussed is NAMPT; the disease is metabolic disease.